全文获取类型
收费全文 | 50724篇 |
免费 | 5361篇 |
国内免费 | 1590篇 |
专业分类
耳鼻咽喉 | 273篇 |
儿科学 | 1746篇 |
妇产科学 | 417篇 |
基础医学 | 6560篇 |
口腔科学 | 1634篇 |
临床医学 | 5344篇 |
内科学 | 10512篇 |
皮肤病学 | 1351篇 |
神经病学 | 2536篇 |
特种医学 | 890篇 |
外国民族医学 | 5篇 |
外科学 | 3784篇 |
综合类 | 8554篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 3118篇 |
眼科学 | 858篇 |
药学 | 5098篇 |
29篇 | |
中国医学 | 3574篇 |
肿瘤学 | 1387篇 |
出版年
2024年 | 65篇 |
2023年 | 1011篇 |
2022年 | 1156篇 |
2021年 | 2271篇 |
2020年 | 2311篇 |
2019年 | 1965篇 |
2018年 | 1869篇 |
2017年 | 2133篇 |
2016年 | 2301篇 |
2015年 | 2067篇 |
2014年 | 3772篇 |
2013年 | 4142篇 |
2012年 | 3890篇 |
2011年 | 3963篇 |
2010年 | 3092篇 |
2009年 | 2875篇 |
2008年 | 2636篇 |
2007年 | 2267篇 |
2006年 | 1996篇 |
2005年 | 1780篇 |
2004年 | 1426篇 |
2003年 | 1166篇 |
2002年 | 1035篇 |
2001年 | 904篇 |
2000年 | 701篇 |
1999年 | 562篇 |
1998年 | 501篇 |
1997年 | 375篇 |
1996年 | 406篇 |
1995年 | 353篇 |
1994年 | 323篇 |
1993年 | 282篇 |
1992年 | 286篇 |
1991年 | 229篇 |
1990年 | 192篇 |
1989年 | 164篇 |
1988年 | 148篇 |
1987年 | 143篇 |
1986年 | 126篇 |
1985年 | 145篇 |
1984年 | 125篇 |
1983年 | 88篇 |
1982年 | 92篇 |
1981年 | 78篇 |
1980年 | 62篇 |
1979年 | 44篇 |
1978年 | 39篇 |
1977年 | 36篇 |
1976年 | 34篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Samira Marín-Romero Teresa Elías-Hernández María Isabel Asensio-Cruz Rocío Ortega-Rivera Raquel Morillo-Guerrero Javier Toral Emilio Montero Verónica Sánchez Elena Arellano José María Sánchez-Díaz Macarena Real-Domínguez Remedios Otero-Candelera Luis Jara-Palomares 《Archivos de bronconeumología》2019,55(12):619-626
IntroductionScales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months.MethodsThis was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration).ResultsOf 353 patients evaluated, 195 were analyzed, with an average age of 53.5 ± 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p <.05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p <.05).ConclusionsOur study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). 相似文献
53.
1型糖尿病(T1D)是一种自身免疫性疾病,目前仍缺乏有效预防和治愈方法,临床上通过早期干预可显著改善T1D的发展进程和预后,而有效的生物学标志物对于T1D早期预测和早期诊断具有重要意义。因此,近年来国内外研究者致力于探索T1D相关生物标志物,发现并确定了一些可作为T1D临床诊断和预测疾病风险的生物标志物,包括遗传标志物、胰岛β细胞自身抗体、T细胞生物标志物及新兴的"组学"生物标志物等。文章总结了已建立的T1D生物标志物及其研究进展。 相似文献
54.
55.
56.
57.
58.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
59.
Jeff Unger MD Dale C. Allison MD Margit Kaltoft MD Kavitha Lakkole MBA Jayant K. Panda MD Chethana Ramesh MSc Mehmet Sargin MD Elena Smolyarchuk MD Melissa Twine BS Benjamin Wolthers MD Gizem Yarimbas MSc Marouan Zoghbi MD the LIRA-PRIME investigators 《Diabetes, obesity & metabolism》2022,24(2):204-211
60.